|
|
Article: NATIONAL HEART, LUNG, BLOOD INSTITUTE AWARDS $170 MILLION TO FUND STEM CELL RESEARCH
- Article from:
- US Fed News Service, Including US State News
- Article date:
- October 8, 2009
CopyrightCopyright © HT Media Ltd. All Rights Reserved. Provided by ProQuest LLC. (Hide copyright information)
|
WASHINGTON, Oct. 7 -- The U.S. Department of Health & Human Services' National Institutes of Health issued the following press release:
The National Heart, Lung, and Blood Institute (NHLBI), one of the National Institutes of Health, has awarded $170 million to be paid over seven years to 18 teams of research scientists to develop the high-potential field of stem and progenitor cell tools and therapies.
The awards create the NHLBI Progenitor Cell Biology Consortium, which will bring together researchers from the heart, lung, blood, and technology research fields. A seven-year project, the consortium assembles nine research hubs with multidisciplinary teams of principal investigators and ...
Related newspaper, magazine, and journal articles:
|
|
Article: Two Industry Leaders Join Progenitor Cell Therapy ...
Business Wire;
October 10, 2006 ;
700+ words
... ... Manufacturing and Market Experts Added to Progenitor Cell Therapy's Board of Managers HACKENSACK, N.J. -- Progenitor Cell Therapy, LLC (PCT), a leading ... an outstanding Board providing Progenitor Cell Therapy with significant guidance ...
|
|